PT-141 (bremelanotide) is a melanocortin receptor agonist peptide that increases sexual arousal by acting on the central nervous system rather than the cardiovascular system. Unlike Viagra and Cialis, which work by improving blood flow, PT-141 works on the brain pathways that initiate sexual desire. It is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women, and used off-label by men for erectile dysfunction that has not responded to PDE-5 inhibitors. This guide covers PT-141 benefits, dosing, side effects, who it is right for, and how it differs from traditional sexual performance drugs.
PT-141 is one of the few peptides that produces a clear effect within 30 to 60 minutes of dosing, which makes it easy to evaluate. See our peptides for sexual performance guide for the full category overview. Customer pattern: works very well for some users (genuine increase in libido and arousal), produces side effects without much benefit for others. The split is biological, not psychological.
What Is PT-141?
PT-141 is a synthetic cyclic 7-amino-acid peptide derived from melanotan II. Where melanotan II was developed for skin tanning effects, the developers noticed it also produced sexual arousal, and PT-141 was created to isolate that effect without the tanning side effect.
Mechanism: PT-141 binds melanocortin receptors (specifically MC4R) in the central nervous system. MC4R activation in the hypothalamus and limbic system triggers the neural pathways for sexual arousal independent of vascular function.
This central mechanism is what makes PT-141 distinct from PDE-5 inhibitors (Viagra, Cialis), which work peripherally on smooth muscle and blood vessels.
PT-141 Benefits
For women: hypoactive sexual desire disorder (HSDD)
FDA-approved use. Trials showed:
- Increased number of “satisfying sexual events” per month
- Improved scores on the Female Sexual Function Index
- Effects mediated by central arousal pathways, not peripheral vasodilation
The female libido market has very few effective pharmaceutical options. PT-141 is one of the few with measurable benefit beyond placebo.
For men: ED unresponsive to PDE-5 inhibitors
Off-label use. Useful when:
- Viagra/Cialis have stopped working
- The ED is psychogenic (mental rather than vascular)
- Vascular function is fine but desire is the limiting factor
- The user wants increased libido alongside erectile function
For both sexes: general libido enhancement
Off-label recreational use. PT-141 produces a clear increase in subjective arousal and desire in many users, lasting 6 to 12 hours after a single dose.
PT-141 Dosing Protocol
- Standard dose: 1 to 2 mg subcutaneous, 30 to 60 minutes before desired effect
- Female dose: 0.5 to 1.75 mg (FDA-approved Vyleesi dose is 1.75 mg)
- Male dose: 1 to 2 mg
- Frequency: PRN (as needed). Not daily. Maximum once per 24 hours, no more than 8 doses per month.
- Onset: 30 to 60 minutes
- Duration: 6 to 12 hours of effect
Critical: PT-141 is not a daily peptide. The melanocortin system tolerates repeated activation poorly, and high frequency use produces diminishing returns plus increased side effects.
Reconstitution
Standard 10 mg vial:
- Add 1 mL bacteriostatic water → 10 mg/mL
- 1 mg dose = 0.1 mL (10 units on insulin syringe)
- 2 mg dose = 0.2 mL (20 units)
Refrigerate after reconstitution; stable 30 days. See our reconstitution guide.
PT-141 Side Effects
The side effect profile is real and worth understanding:
- Nausea (40 to 60% of users): most common side effect. Usually mild, sometimes pronounced. Subsides within 1 to 2 hours of dose.
- Flushing: facial and chest flushing common in first 30 minutes after dose
- Headache: 10 to 20% of users, mild to moderate
- Brief blood pressure increase: 6 mmHg systolic on average, returning to baseline within 6 hours
- Skin darkening: with frequent use, slight tanning effect (residual from PT-141’s parent molecule, melanotan II)
- Fatigue: some users feel tired for 1 to 2 hours after dose
The nausea is what stops some users from continuing. For users who experience severe nausea, smaller doses (0.5 to 1 mg) often produce the libido benefit with less GI effect.
Who Should Avoid PT-141
- Users with uncontrolled hypertension (the BP elevation matters)
- Users with cardiovascular disease, recent heart attack, or arrhythmia
- Pregnant or breastfeeding women
- Users on blood pressure medications who cannot monitor BP changes
- Users with hypersensitivity to peptide drugs
PT-141 vs Viagra vs Cialis
| Property | PT-141 | Viagra (Sildenafil) | Cialis (Tadalafil) |
|---|---|---|---|
| Mechanism | Central (CNS) | Peripheral (vascular) | Peripheral (vascular) |
| Onset | 30 to 60 min | 30 to 60 min | 2 hours |
| Duration | 6 to 12 hours | 4 to 6 hours | 24 to 36 hours |
| Affects desire | Yes | No (only vascular response) | No |
| Works for women | Yes (FDA approved) | Limited evidence | Limited evidence |
| Form | Subcutaneous injection | Oral tablet | Oral tablet |
| Major side effect | Nausea | Headache, flushing | Back pain, headache |
PT-141 fills the gap PDE-5 inhibitors leave: it addresses desire and arousal at the brain level, not just blood flow downstream. For users whose ED is rooted in low desire rather than vascular failure, PDE-5 inhibitors miss the actual problem.
PT-141 Stacking
Common combinations:
- PT-141 + Viagra/Cialis: dual mechanism (central + peripheral). Some users find this combination produces complete arousal and erectile response when neither alone is sufficient. Take Viagra/Cialis first to allow for slower onset.
- PT-141 + L-Citrulline: peripheral vascular support without prescription PDE-5 inhibitors.
- Avoid stacking with melanotan II: redundant mechanism, increased nausea and skin darkening.
Common PT-141 Mistakes
- Taking on a full stomach: amplifies nausea. Light meal 1 to 2 hours before dosing is the sweet spot.
- Taking too high a dose first time: 2 mg is the upper end. New users should start with 1 mg and assess tolerance before dose-escalating.
- Frequent use: melanocortin system tolerates poorly. More than 1 to 2 doses per week reduces effect and increases side effects.
- Expecting Viagra-like erection mechanism: PT-141 increases desire and arousal, not just vascular response. The effect is qualitatively different.
- Ignoring blood pressure response: track BP if you have any cardiovascular concerns.
Frequently Asked Questions
How long does PT-141 last?
The acute libido and arousal effect lasts 6 to 12 hours. Some users report mild residual effect for 24 hours. Plan dosing around when you want the effect window.
Will PT-141 work the first time?
For about 60 to 70% of users, yes. For others, the effect builds over 2 to 3 doses or is too mild to be useful. The biological response varies.
Is PT-141 safe for older men?
The cardiovascular effects (BP, heart rate) make it more risky for older men with hypertension or heart disease. Younger or healthier men tolerate it well.
Can PT-141 be used daily?
No. Daily use causes melanocortin desensitization and increased side effects without proportional benefit. PRN dosing only, maximum 8 doses per month.
Does PT-141 cause permanent libido changes?
No. Effects are limited to the 6 to 12 hour active window. No carryover libido enhancement after the dose clears, no permanent libido changes from use.
Where can I get PT-141?
For research-grade PT-141 (bremelanotide) in Indonesia and Southeast Asia, see our pricelist. Order directly via WhatsApp.
This article is for informational and research-use purposes only. PT-141 (Vyleesi) is FDA-approved only for HSDD in premenopausal women. Off-label uses should be discussed with a qualified medical professional.